Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling

J Dermatol. 2017 Sep;44(9):e226-e227. doi: 10.1111/1346-8138.13898. Epub 2017 Apr 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Female
  • Humans
  • Keratoacanthoma / chemically induced*
  • Keratoderma, Palmoplantar / chemically induced*
  • Melanoma / drug therapy*
  • Middle Aged
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors*
  • Protein Kinase Inhibitors / adverse effects*
  • Skin Neoplasms / drug therapy*
  • Vemurafenib / adverse effects*

Substances

  • Protein Kinase Inhibitors
  • Vemurafenib
  • Mitogen-Activated Protein Kinase Kinases